Want to join the conversation?
The BoD of $HSIC, a provider of health care products and services, increased the share repurchase of up to $400MM of its common stock. The company has already authorized a $400MM repurchase program in December 2015, in which approx. $29MM remaining authorized for future repurchases.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.